Pharma Journalist -

Lifecore Biomedical, Inc. and PolyPeptide Laboratories, Inc. have announced a collaboration to offer fully integrated development and manufacturing services for peptide-based…
Read More...

Tokyo - February 26-27, 2026 - The Targeted Therapies Partnering & Licensing Summit Asia is set to unite industry leaders, investors, and biopharma innovators across the region to…
Read More...

GSK plc has entered into an agreement with Syndivia, a private biotechnology company specializing in next-generation antibody-drug conjugates (ADCs), granting GSK exclusive worldwide…
Read More...

Eli Lilly and Company announced it will acquire Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage biotechnology company pioneering intravitreal gene therapies for eye…
Read More...

Alkermes plc has announced plans to acquire Avadel Pharmaceuticals plc in a $2.1 billion all-cash deal, marking a major strategic move to expand its presence into the fast-growing sleep…
Read More...

Ipsen has announced plans to acquire ImCheck Therapeutics, a private French biotechnology company developing next-generation immuno-oncology treatments, in a deal that expands Ipsen’s…
Read More...

GSK plc announced today that the US Food and Drug Administration (FDA) has approved its cancer therapy Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and…
Read More...

Takeda Pharmaceutical Company has entered a license and collaboration agreement with Innovent Biologics to develop, manufacture and commercialize two late-stage oncology medicines —…
Read More...

Ventus Therapeutics, a clinical-stage biopharmaceutical company, has announced a multi-year collaboration with Genentech, part of the Roche Group, to discover and optimize novel…
Read More...

Roche announced positive results from the Phase III IMvigor011 study evaluating Tecentriq® (atezolizumab) as an adjuvant treatment for muscle-invasive bladder cancer (MIBC) in patients…
Read More...